MBXMBX Biosciences Inc. Common Stock
66.33USD-3.03%Mkt Cap: 3.19B $P/E: —3d ago
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidat…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap3.19B $
Enterprise Value2.78B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-86.97M $
Revenue/Share—
Last Price66.33 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees63
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-16.83
PEG—
EV/EBITDA-23.63
EV/Revenue—
P/S—
P/B7.21
EPS (TTM)-2.30
EPS (Forward)-3.94
52W Range
9.63090% of range72.64
52W High72.64 USD
52W Low9.630 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-23.56%
ROA-22.58%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-79.95M $
CapEx (TTM)1.93M $
FCF Margin—
FCF Yield-1.66%
Net Debt-415.24M $
Net Debt/EBITDA3.53
Balance Sheet
Debt/Equity0.00
Current Ratio18.08
Quick Ratio17.82
Book Value/Sh9.202 USD
Cash/Share8.691 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)88.40 USD
Upside (mean)+33.3%
Target Range70.00 USD – 121.00 USD
$70.00+33.3% to mean$121.00
# Analysts10
Ownership
Shares Out.48.16M
Float30.99M
Insiders2.82%
Institutions115.74%
Short Interest
Short Ratio6.7d
Short % Float15.14%
Short % Out.10.82%
Shares Short5.19M
Short (prev mo.)5.90M
Technical
SMA 5058.04 (+14.3%)
SMA 20038.51 (+72.2%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)583.36K
Avg Vol (10d)440.68K
Technical Indicators
RSI (14)55.4
MACD2.4406
MACD Signal3.1233
MACD Hist.-0.6828
BB Upper71.14 USD
BB Middle66.29 USD
BB Lower61.45 USD
BB Width14.61%
ATR (14)3.725 USD
Vol Ratio (20d)0.91x